Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial
- PMID: 23941362
- PMCID: PMC3751456
- DOI: 10.1186/1475-2891-12-119
Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial
Abstract
Background: In patients with chronic hepatitis C (CHC), obesity is involved in the pathogenesis of insulin resistance, fatty liver disease and progression of fibrosis. The objective of this study was to compare a normoglucidic low-calorie diet (NGLCD) with a low-fat diet (LFD) among participants with CHC. Aimed to measure the impact of dietary changes in reduction of insulin resistance, obesity but also in steatosis and fibrosis.
Methods: Randomized, controlled trial in three medical centers with assessments at baseline, 6 months and 12 months. Participants were patients over 35 years with chronic hepatitis C (n = 120) with BMI over 25 kg/m². We evaluated the effects of NGLCD vs. LFD in weight management and metabolic improvement. The primary endpoint was to measure the impact of dietary changes through nutritional intervention in reversibility of insulin resistance, obesity, steatosis, and fibrosis. We performed anthropometric measurements, fasting glucose profile, serum lipids, liver profile, blood count at baseline, 6 and 12 months. Steatosis was evaluated using ultrasonographic criteria. Liver fibrosis was non-invasively assessed.
Results: After 6 and 12 months of intervention, both groups had a significant decrease in caloric consumption. At 6 months, weight loss was greater in the NGLCD group (-5.02 ± 3.43 kg vs. -4.1 ± 2.6 kg; p = 0.002) compared to the LFD group. At 1-year, however, weight loss was similar in both groups (-3.9 ± 3.3 kg vs. -3.1 ± 2.6 kg; p = 0.139). At 12 months, fasting plasma glucose, fasting plasma insulin, and HOMA-IR had significant improvements in both groups. With both diets aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transpeptidase (GGT) decreased with significant differences; also there were significant improvements in AST/ALT ratio, Forns fibrosis index. The two diets were associated with reduction of both the prevalence and the severity of steatosis (all p < 0.001). At 12 months, total cholesterol, HDL-cholesterol, triglycerides improved in both groups (all p < 0.05).
Conclusions: The present study establishes the benefits of low-calorie diet and low-fat diet in management of patients with hepatitis C regarding improvement of insulin resistance, steatosis and also fibrosis.Overweight or obese patients with CHC undergoing a lifestyle intervention (specific dietary intervention and physical activity) for 1-year had significant improvements in body weight, lipid and hepatic profile.
Trial registration: PNCI2-3343/41008/2007.
Similar articles
-
Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.Nutrients. 2024 May 8;16(10):1408. doi: 10.3390/nu16101408. Nutrients. 2024. PMID: 38794646 Free PMC article.
-
Effect of a Low-Calorie Dietary Intervention on Liver Health and Body Weight in Adults with Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Overweight/Obesity: A Systematic Review and Meta-Analysis.Nutrients. 2024 Apr 1;16(7):1030. doi: 10.3390/nu16071030. Nutrients. 2024. PMID: 38613063 Free PMC article. Review.
-
The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.Scand J Gastroenterol. 2022 Oct;57(10):1238-1249. doi: 10.1080/00365521.2022.2071109. Epub 2022 Jun 16. Scand J Gastroenterol. 2022. PMID: 35710164 Clinical Trial.
-
Fasting, Nutrition and Weight Loss: An Approach to Refine Non-Alcoholic Fatty Liver Disease.J Nutr Sci Vitaminol (Tokyo). 2021;67(6):366-374. doi: 10.3177/jnsv.67.366. J Nutr Sci Vitaminol (Tokyo). 2021. PMID: 34980714 Review.
-
Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.Eur J Intern Med. 2015 Jan;26(1):30-6. doi: 10.1016/j.ejim.2014.12.001. Epub 2014 Dec 29. Eur J Intern Med. 2015. PMID: 25553983
Cited by
-
Overview of Complications in Cirrhosis.J Clin Exp Hepatol. 2022 Jul-Aug;12(4):1150-1174. doi: 10.1016/j.jceh.2022.04.021. Epub 2022 May 14. J Clin Exp Hepatol. 2022. PMID: 35814522 Free PMC article. Review.
-
Long Term Weight Loss Diets and Obesity Indices: Results of a Network Meta-Analysis.Front Nutr. 2022 Apr 5;9:821096. doi: 10.3389/fnut.2022.821096. eCollection 2022. Front Nutr. 2022. PMID: 35479754 Free PMC article.
-
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020.J Gastroenterol. 2021 Jul;56(7):593-619. doi: 10.1007/s00535-021-01788-x. Epub 2021 Jul 7. J Gastroenterol. 2021. PMID: 34231046 Free PMC article. Review.
-
Effects of total fat intake on body fatness in adults.Cochrane Database Syst Rev. 2020 Jun 1;6(6):CD013636. doi: 10.1002/14651858.CD013636. Cochrane Database Syst Rev. 2020. PMID: 32476140 Free PMC article.
-
Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care.Medicine (Baltimore). 2016 Oct;95(41):e5048. doi: 10.1097/MD.0000000000005048. Medicine (Baltimore). 2016. PMID: 27741116 Free PMC article. Review.
References
-
- Gheorghe L, Grigorescu M, Iacob S, Damian D, Gheorghe C, Iacob R, Simionov I, Vadan R, Parvulescu I, Bancila I. Effectiveness and tolerability of pegylated Interferon alpha-2a and ribavirin combination therapy in Romanian patients with chronic hepatitis C: from clinical trials to clinical practice. Rom J Gastroenterol. 2005;14:109–115. - PubMed
-
- Lonardo A, Ballestri S, Restivo L, Adinolfi L, Loria P. Hepatitis C and cardiovascular risk: facts and controversies. Hot Topics In Viral Hepatitis. 2012;24:27–35.
-
- World Health Organization. Obesity: preventing and managing the global epidemic: report of a World Health Organization Consultation. Geneva, Switzerland: World Health Organization; 1997. - PubMed
-
- Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, Karimbakas J. The National High Blood Pressure Education Program Coordinating Committee. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;88:1882–1888. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous